SCHEMBL1820258

SCHEMBL1820258

COc1cc(-c2ccc3c(c2)N(S(=O)(=O)c2ccc(C(F)(F)F)cc2)CCO3)ccc1C#N

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.45
▸ NR1H3 Q13133 2/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ RORC P51449 1/20 0.44
▸ NR1H2 P55055 1/20 0.44
▸ GAA P10253 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ SCN9A Q15858 8/20 0.41
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ TP53 P04637 1/20 0.40
▸ CYP11B1 P15538 1/20 0.40
▸ SCN5A Q14524 5/20 0.39
▸ NOX4 Q9NPH5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1819918 0.90 NPC1 (0.48) NPC1NR1H3CYP2C9RORCNR1H2
SCHEMBL1818007 0.89 CYP2C9 (0.56) NPC1CYP2C9GAAPOLBCYP3A4
SCHEMBL1818577 0.89 NPC1 (0.58) NPC1CYP2C9POLBCYP3A4CYP2D6
SCHEMBL1816318 0.88 NPC1 (0.47) NPC1CYP2C9GAAPOLBCYP3A4
SCHEMBL1819920 0.88 NPC1 (0.47) NPC1NR1H3CYP2C9RORCNR1H2
SCHEMBL1818967 0.88 CYP2C9 (0.48) NPC1NR1H3CYP2C9RORCNR1H2
SCHEMBL1817694 0.86 POLB (0.46) NPC1CYP2C9GAAPOLBCYP3A4
SCHEMBL1819412 0.86 NPC1 (0.45) NPC1NR1H3CYP2C9RORCNR1H2
SCHEMBL1818733 0.86 CYP2C9 (0.47) NPC1CYP2C9POLBCYP3A4CYP2D6
SCHEMBL1816628 0.85 POLB (0.45) NPC1CYP2C9GAAPOLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO claimed
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO disclosed
Send feedback